• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXSL2101143 特立帕肽注射液 teriparatide Injection Biological Products(3.3) Import Drug Application 2021-12-02 Alvogen Inc view
CXSS2200068 特立帕肽注射液 teriparatide Injection Biological Products(3.3) New Drug Application 2022-07-19 Shanghai United Cell Biotechnology Co Ltd view
JYSB2400162 特立帕肽注射液 teriparatide Injection Biological Products Supplementary Application 2024-07-18 Lilly France;Eli Lilly Nederland BV view
JYSB2200082 特立帕肽注射液 teriparatide Injection Biological Products Supplementary Application 2022-05-10 Lilly France;Eli Lilly Nederland BV view
JYSZ2400027 特立帕肽注射液 teriparatide Injection Biological Products License Renew 2024-05-17 Lilly France;Eli Lilly Nederland BV;Lilly Suzhou Pharmaceutical Co Ltd view
CXSS2200073 特立帕肽注射液 teriparatide Injection Biological Products(3.3) New Drug Application 2022-08-16 Wuxi Hebang Bio-Tech Co Ltd view
CXHL2400319 特立帕肽注射液 teriparatide Injection Chemical Drugs(2.2) New Drug Application 2024-03-29 Yunnan Xianshi Pharmaceutical Co Ltd view
CYSB2500021 特立帕肽注射液 teriparatide Injection Biological Products(3.3) Supplementary Application 2025-01-22 Suzhou Genemen Biotech Co Ltd view
CXSS2200062 特立帕肽注射液 teriparatide Injection Biological Products(3.3) New Drug Application 2022-06-29 Beijing Genetech Pharmaceutical Co Ltd view
CXHS2400015 特立帕肽注射液 teriparatide Injection Chemical Drugs(2.2) New Drug Application 2024-02-23 Hybio Pharmaceutical Co Ltd view
JTH2400172 特立帕肽注射液 teriparatide Injection Chemical Drugs Disposable Import Drug Application 2024-10-11 Shanghai Ambio Inc;Ambio Pharma Europe;Novocol Pharmaceutical of Canada Inc view
JTS2100540 特立帕肽注射液 teriparatide Injection Biological Products Disposable Import Drug Application 2021-10-27 Eli Lilly & Co (Taiwan) Inc;Lilly France;Shanghai United Cell Biotechnology Co Ltd view
CXSL2300676 特立帕肽注射液 teriparatide Injection Biological Products(3.3) New Drug Application 2023-10-09 Shanghai Duomirui Biotechnology Co Ltd view
CXSL2400506 特立帕肽注射液 teriparatide Injection Biological Products(3.3) New Drug Application 2024-08-01 Shanghai Duomirui Biotechnology Co Ltd view
JXSS0900009 特立帕肽注射液 teriparatide Injection Biological Products Import Drug Application 2009-08-20 Eli Lilly Nederland B.V. Eli Lilly Nederland BV;Lilly France Certificate Issued 2011-03-16 view
JYSB1100188 特立帕肽注射液 teriparatide Injection Biological Products Supplementary Application 2011-08-17 Eli Lilly Nederland B.V. Eli Lilly Nederland BV;Lilly France Certificate Issued 2013-04-27 view
CXSL1500015 特立帕肽注射液 teriparatide Injection Biological Products(15) New Drug Application 2015-06-15 上海联合赛尔生物工程有限公司 Shanghai United Cell Biotechnology Co Ltd Certificate Issued 2016-09-03 view
JYSB1500257 特立帕肽注射液 teriparatide Injection Biological Products Supplementary Application 2015-10-12 Eli Lilly Nederland B.V. Eli Lilly Nederland BV;Lilly France Certificate Issued 2017-06-02 view
CYHS1301153 特立帕肽注射液 teriparatide Injection Chemical Drugs(6) Generic Drug 2014-04-28 深圳翰宇药业股份有限公司 Hybio Pharmaceutical Co Ltd Certificate Issued 2017-09-20 view
CXSL1800036 重组特立帕肽注射液 teriparatide Injection Biological Products(15) New Drug Application 2018-04-24 上海联合赛尔生物工程有限公司 Shanghai United Cell Biotechnology Co Ltd Certificate Issued 2018-10-08 view